Fibroblast growth factor 21 improves insulin sensitivity by modulating the bile acid-gut microbiota axis in type Ⅱ diabetic mice

This publication has 48 references indexed in Scilit:

• Bile Acid Biology, Pathophysiology, and Therapeutics
  Clinical Liver Disease, 2020
• Gut microbiota mediates diurnal variation of acetaminophen induced acute liver injury in mice
  Journal of Hepatology, 2018
• From Dietary Fiber to Host Physiology: Short-Chain Fatty Acids as Key Bacterial Metabolites
  Cell, 2016
• Insulin-like peptide 5 is a microbially regulated peptide that promotes hepatic glucose production
  Molecular Metabolism, 2016
• Fibroblast Growth Factor 21 As an Emerging Therapeutic Target for Type 2 Diabetes Mellitus
  Medicinal Research Reviews, 2016
• Adiponectin Mediates the Metabolic Effects of FGF21 on Glucose Homeostasis and Insulin Sensitivity in Mice
  Cell Metabolism, 2013
• Human intestinal microbiota composition is associated with local and systemic inflammation in obesity
  Obesity, 2013
• Specificity of Polysaccharide Use in Intestinal Bacteroides Species Determines Diet-Induced Microbiota Alterations
  Cell, 2010
• Fibroblast growth factor 15 functions as an enterohepatic signal to regulate bile acid homeostasis
  Cell Metabolism, 2005
• Combination of high-fat diet-fed and low-dose streptozotocin-treated rat: A model for type 2 diabetes and pharmacological screening
  Pharmacological Research, 2005